Event category: Concurrent

The world of healthcare is constantly evolving, driven by technological advances, research breakthroughs, and the need for improved patient outcomes. Allied professionals are at the forefront of this evolution, playing pivotal roles in both clinical and industry settings. This session will explore how these professionals can bridge the gap between industry roles in companies and traditional clinical roles. Join us for a panel discussion that will share strategies and insights on how allied professionals can navigate their careers, contribute to innovation, and enhance healthcare delivery across both arenas.

In this session, we will explore how data - powered by AI - is impacting how we deliver care to patients with heart failure.

Photoplethysmography (PPG) is being used to detect biologic parameters becuase it provides a non-invasive and inexpensive tool when coupled to a smartphone. In particular, there has been interest in using PPG for the detection of arrhythmias such as atrial fibrillation, measurement of ambulatory blood pressure, and even identification of patients with sleep apnea. In this session, we will explore whether PPG is sufficient for detection and monitoring of these conditions.

The day-to-day practice of Cardiology has long involved use of the stethoscope, electrocardiogram and echocardiogram for assessment of patients. However, AI is completely transforming the value proposition of these "old tools", which are rapidly being transformed into disease prediction and disease identification tools. This panel will discuss the latest iterations in these "old-time" tools.

In this session, we will explore use of digital care pathways for patient education and to determine patient reported outcomes as well as institution level outcomes after interventions such as atrial fibrillation ablation

The HRX 2024 Pitch Competition provides cardiovascular startups with a platform to present their innovative products, services, and solutions to a distinguished panel of judges and potential investors and win cash prices. The top five teams selected will compete on the HRX Main Stage. Each team will have 10 minutes to creatively pitch their innovative idea, followed by five minutes to field questions from judges and attendees.

Although a large body of research has succeeded in identifying certain patient populations at high risk for sudden cardiac arrest, the vast majority are not identified prior to the occurrence of sudden cardiac arrest.

This session will address the next frontier for digital health - helping to overcome the challenges in identification, rapid response and treatment out of hospital cardiac arrest. Our panel will include key stakeholders: emergency and electrophysiology physicians, tech developers and researchers, those at the federal and legislative level, as well as large tech companies that will help drive a panel discussion focusing on how to drive the digital space in forward to ultimately help improve OHCA outcomes.

Investments in cardiology devices, including digital health and AI have been in decline over the past 2 years leading many to wonder “what are investors looking for?” In this session, we will explore the current trends of investments in Cardiology, Digital Health and AI and learn from current investors who invest at all stages along the technology life cycle.

10+ years of “point solution” pilots, and over $100B venture capital later, the digital health implementation “playbook” is being rewritten. The acceleration of generative AI in a capital-constrained environment, alongside demands for value-based care models, are changing the way we design clinical workflows, train staff, onboard patients, launch programs, and measure success. In this panel we will explore how technical advances and economic pressures are shaping the way that companies and health systems design, launch, and scale digital health solutions.